Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 6, p. 1131, doi. 10.1007/s10557-022-07356-6
- By:
- Publication type:
- Article
Works by Chen, Yanghao
Results: 5
1
2
Costunolide attenuates high‐fat diet‐induced inflammation and oxidative stress in non‐alcoholic fatty liver disease.
- Published in:
- Drug Development Research, 2024, v. 85, n. 1, p. 1, doi. 10.1002/ddr.22150
- By:
- Publication type:
- Article
3
The Complement System in Retinal Detachment with Choroidal Detachment.
- Published in:
- Current Eye Research, 2022, v. 47, n. 5, p. 809, doi. 10.1080/02713683.2022.2038634
- By:
- Publication type:
- Article
4
Tabersonine attenuates obesity‐induced renal injury via inhibiting NF‐κB‐mediated inflammation.
- Published in:
- Phytotherapy Research, 2023, v. 37, n. 6, p. 2353, doi. 10.1002/ptr.7756
- By:
- Publication type:
- Article
5
Tabersonine alleviates obesity‐induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1‐mediated inflammation.
- Published in:
- Phytotherapy Research, 2023, v. 37, n. 3, p. 860, doi. 10.1002/ptr.7666
- By:
- Publication type:
- Article